Titre : Sirtuine-1

Sirtuine-1 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sirtuine-1 : Questions médicales les plus fréquentes", "headline": "Sirtuine-1 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sirtuine-1 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-13", "dateModified": "2025-04-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sirtuine-1" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sirtuines", "url": "https://questionsmedicales.fr/mesh/D037761", "about": { "@type": "MedicalCondition", "name": "Sirtuines", "code": { "@type": "MedicalCode", "code": "D037761", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.900" } } }, "about": { "@type": "MedicalCondition", "name": "Sirtuine-1", "alternateName": "Sirtuin 1", "code": { "@type": "MedicalCode", "code": "D056564", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Giulia Bononi", "url": "https://questionsmedicales.fr/author/Giulia%20Bononi", "affiliation": { "@type": "Organization", "name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it." } }, { "@type": "Person", "name": "Valentina Citi", "url": "https://questionsmedicales.fr/author/Valentina%20Citi", "affiliation": { "@type": "Organization", "name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it." } }, { "@type": "Person", "name": "Alma Martelli", "url": "https://questionsmedicales.fr/author/Alma%20Martelli", "affiliation": { "@type": "Organization", "name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it." } }, { "@type": "Person", "name": "Giulio Poli", "url": "https://questionsmedicales.fr/author/Giulio%20Poli", "affiliation": { "@type": "Organization", "name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it." } }, { "@type": "Person", "name": "Tiziano Tuccinardi", "url": "https://questionsmedicales.fr/author/Tiziano%20Tuccinardi", "affiliation": { "@type": "Organization", "name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Outcome Evaluation of a Transnational Postgraduate Capacity-Building Program Using the Objective Structured Clinical Examination.", "datePublished": "2023-02-24", "url": "https://questionsmedicales.fr/article/36840345", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/0193841X231160805" } }, { "@type": "ScholarlyArticle", "name": "Comparing the gut microbiome of obese, African American, older adults with and without mild cognitive impairment.", "datePublished": "2023-02-24", "url": "https://questionsmedicales.fr/article/36827280", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0280211" } }, { "@type": "ScholarlyArticle", "name": "Rs28446116 in PTCH1 is associated with non-syndromic cleft lip with or without palate in the Ningxia population, China.", "datePublished": "2023-02-23", "url": "https://questionsmedicales.fr/article/36870116", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.archoralbio.2023.105660" } }, { "@type": "ScholarlyArticle", "name": "Application of an", "datePublished": "2023-02-23", "url": "https://questionsmedicales.fr/article/36680346", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/17461391.2023.2171906" } }, { "@type": "ScholarlyArticle", "name": "Comorbidity of Urogynecological and Gastrointestinal Disorders in Female Patients With Lichen Sclerosus.", "datePublished": "2023-02-23", "url": "https://questionsmedicales.fr/article/36821789", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/LGT.0000000000000727" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines et peptides de signalisation intracellulaire", "item": "https://questionsmedicales.fr/mesh/D047908" }, { "@type": "ListItem", "position": 5, "name": "Sirtuines", "item": "https://questionsmedicales.fr/mesh/D037761" }, { "@type": "ListItem", "position": 6, "name": "Sirtuine-1", "item": "https://questionsmedicales.fr/mesh/D056564" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sirtuine-1 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sirtuine-1", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sirtuine-1", "description": "Comment évaluer le niveau de Sirtuine-1 ?\nQuels tests sont utilisés pour la Sirtuine-1 ?\nY a-t-il des biomarqueurs associés à Sirtuine-1 ?\nLa génétique influence-t-elle Sirtuine-1 ?\nPeut-on mesurer Sirtuine-1 dans les tissus ?", "url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Case-Control+Studies&page=999#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sirtuine-1", "description": "Quels symptômes sont liés à une faible Sirtuine-1 ?\nLa Sirtuine-1 affecte-t-elle le vieillissement ?\nQuels effets sur la santé mentale ?\nY a-t-il des symptômes de maladies liées à Sirtuine-1 ?\nSirtuine-1 influence-t-elle l'énergie cellulaire ?", "url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Case-Control+Studies&page=999#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sirtuine-1", "description": "Comment prévenir la baisse de Sirtuine-1 ?\nLe stress affecte-t-il Sirtuine-1 ?\nY a-t-il des habitudes à éviter ?\nLe sommeil influence-t-il Sirtuine-1 ?\nDes suppléments pour Sirtuine-1 ?", "url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Case-Control+Studies&page=999#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sirtuine-1", "description": "Quels traitements augmentent Sirtuine-1 ?\nY a-t-il des médicaments ciblant Sirtuine-1 ?\nComment la nutrition affecte-t-elle Sirtuine-1 ?\nL'exercice physique influence-t-il Sirtuine-1 ?\nDes thérapies géniques pour Sirtuine-1 ?", "url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Case-Control+Studies&page=999#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sirtuine-1", "description": "Quelles complications sont liées à une faible Sirtuine-1 ?\nSirtuine-1 et maladies cardiovasculaires ?\nY a-t-il un lien avec le diabète ?\nSirtuine-1 et cancer ?\nComplications neurologiques liées à Sirtuine-1 ?", "url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Case-Control+Studies&page=999#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sirtuine-1", "description": "Quels facteurs augmentent le risque de faible Sirtuine-1 ?\nL'alimentation influence-t-elle Sirtuine-1 ?\nLe mode de vie sédentaire affecte-t-il Sirtuine-1 ?\nLe tabagisme impacte-t-il Sirtuine-1 ?\nLe stress oxydatif influence-t-il Sirtuine-1 ?", "url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Case-Control+Studies&page=999#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer le niveau de Sirtuine-1 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le niveau de Sirtuine-1 peut être mesuré par des tests sanguins ou des biopsies tissulaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour la Sirtuine-1 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biochimiques et des analyses protéomiques sont utilisés pour évaluer Sirtuine-1." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs associés à Sirtuine-1 ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des biomarqueurs comme les niveaux de NAD+ peuvent être associés à Sirtuine-1." } }, { "@type": "Question", "name": "La génétique influence-t-elle Sirtuine-1 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des variations génétiques peuvent affecter l'expression de Sirtuine-1." } }, { "@type": "Question", "name": "Peut-on mesurer Sirtuine-1 dans les tissus ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, Sirtuine-1 peut être mesurée dans des échantillons de tissus par immunohistochimie." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une faible Sirtuine-1 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une faible Sirtuine-1 peut être associée à des troubles métaboliques et à l'inflammation." } }, { "@type": "Question", "name": "La Sirtuine-1 affecte-t-elle le vieillissement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, Sirtuine-1 est impliquée dans la régulation du vieillissement cellulaire et de la longévité." } }, { "@type": "Question", "name": "Quels effets sur la santé mentale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux anormaux de Sirtuine-1 peuvent influencer l'humeur et la cognition." } }, { "@type": "Question", "name": "Y a-t-il des symptômes de maladies liées à Sirtuine-1 ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète et les maladies neurodégénératives sont liées à Sirtuine-1." } }, { "@type": "Question", "name": "Sirtuine-1 influence-t-elle l'énergie cellulaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, Sirtuine-1 joue un rôle clé dans la régulation de l'énergie cellulaire et du métabolisme." } }, { "@type": "Question", "name": "Comment prévenir la baisse de Sirtuine-1 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un mode de vie sain avec une bonne nutrition et de l'exercice aide à prévenir la baisse." } }, { "@type": "Question", "name": "Le stress affecte-t-il Sirtuine-1 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut réduire l'expression de Sirtuine-1 dans les cellules." } }, { "@type": "Question", "name": "Y a-t-il des habitudes à éviter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et une alimentation riche en sucres peut aider à maintenir Sirtuine-1." } }, { "@type": "Question", "name": "Le sommeil influence-t-il Sirtuine-1 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un sommeil de qualité est essentiel pour maintenir des niveaux optimaux de Sirtuine-1." } }, { "@type": "Question", "name": "Des suppléments pour Sirtuine-1 ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments comme le resvératrol peuvent être bénéfiques pour soutenir Sirtuine-1." } }, { "@type": "Question", "name": "Quels traitements augmentent Sirtuine-1 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements comme le resvératrol et l'exercice physique peuvent augmenter Sirtuine-1." } }, { "@type": "Question", "name": "Y a-t-il des médicaments ciblant Sirtuine-1 ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments expérimentaux visent à moduler l'activité de Sirtuine-1." } }, { "@type": "Question", "name": "Comment la nutrition affecte-t-elle Sirtuine-1 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en polyphénols peut stimuler l'expression de Sirtuine-1." } }, { "@type": "Question", "name": "L'exercice physique influence-t-il Sirtuine-1 ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier est connu pour augmenter les niveaux de Sirtuine-1 dans le corps." } }, { "@type": "Question", "name": "Des thérapies géniques pour Sirtuine-1 ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours sur les thérapies géniques pour moduler Sirtuine-1." } }, { "@type": "Question", "name": "Quelles complications sont liées à une faible Sirtuine-1 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Une faible Sirtuine-1 est liée à des maladies métaboliques et à des troubles neurodégénératifs." } }, { "@type": "Question", "name": "Sirtuine-1 et maladies cardiovasculaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux bas de Sirtuine-1 peuvent augmenter le risque de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Y a-t-il un lien avec le diabète ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une faible Sirtuine-1 est associée à une résistance à l'insuline et au diabète de type 2." } }, { "@type": "Question", "name": "Sirtuine-1 et cancer ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent que Sirtuine-1 pourrait jouer un rôle dans la progression de certains cancers." } }, { "@type": "Question", "name": "Complications neurologiques liées à Sirtuine-1 ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une dysrégulation de Sirtuine-1 est liée à des maladies comme Alzheimer et Parkinson." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de faible Sirtuine-1 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le vieillissement et le stress chronique augmentent le risque de faible Sirtuine-1." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle Sirtuine-1 ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation pauvre en nutriments peut réduire l'expression de Sirtuine-1." } }, { "@type": "Question", "name": "Le mode de vie sédentaire affecte-t-il Sirtuine-1 ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire est un facteur de risque pour une faible Sirtuine-1." } }, { "@type": "Question", "name": "Le tabagisme impacte-t-il Sirtuine-1 ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est associé à une diminution des niveaux de Sirtuine-1 dans l'organisme." } }, { "@type": "Question", "name": "Le stress oxydatif influence-t-il Sirtuine-1 ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress oxydatif peut réduire l'activité de Sirtuine-1 et affecter la santé cellulaire." } } ] } ] }

Sources (10000 au total)

Rs28446116 in PTCH1 is associated with non-syndromic cleft lip with or without palate in the Ningxia population, China.

To investigate the association between PTCH1 single nucleotide polymorphism(SNP) and non-syndromic cleft lip with or without palate (NSCL/P) in the Ningxia Hui Autonomous region and predict the functi... A case-control analysis of 31 single nucleotide polymorphism locus alleles on PTCH1 gene (504 cases and 455 controls) was performed to explore the association between PTCH1 gene polymorphisms and non-... The case-control study showed that 5 of the 31 single nucleotide polymorphism loci rs357564 (P = 0.0233), rs1805155 (P = 0.0371), rs28446116 (P = 0.0408), rs2282041 (P = 0.0439), rs56119276 (P = 0.025... PTCH1 gene may be associated with the occurrence of non-syndromic cleft lip with or without palate in the Ningxia region, which may be related to the role of EP300 and RUNX3 in the development of clef...

Comorbidity of Urogynecological and Gastrointestinal Disorders in Female Patients With Lichen Sclerosus.

Lichen sclerosus (LS) is a chronic inflammatory disease with a significant impact on quality of life. The aim of this cross-sectional case-control study was to characterize concomitant urogynecologica... A medical records search between 2004 and 2012 yielded 455 women and girls (mean age 64 years) with LS. The study cohort was compared with a 10-fold age- and sex-matched control cohort. Gynecological ... The well-known association between LS and increased risk of vulvar cancer and its precursors was also found in our study (relative risk [RR] = 100.0; p < .001 and high-grade squamous intraepithelial l... We found that female patients with LS have an increased risk for gynecological cancers as well as for several urogynecological and gastrointestinal disorders. Increased awareness is required to identi...

Socioeconomic disparity in the association between fine particulate matter exposure and papillary thyroid cancer.

Limited data exists suggesting that cumulative exposure to air pollution in the form of fine particulate matter (aerodynamic diameter ≤ 2.5 μm [PM... Under IRB approval, we conducted a case-control study of adult patients (age ≥ 18) newly diagnosed with PTC between 1/2013-12/2016 across a single health care system were identified using electronic m... A cohort of 1990 patients with PTC and a control group of 6919 patients without thyroid disease were identified. Compared to the control group, patients with PTC were more likely to be older (51.2 vs.... Cumulative exposure to PM...

Correlation of serum citrullinated histone H3 levels with disease activity in patients with rheumatoid arthritis.

Serum citrullinated histone H3 (CitH3) levels in humans with rheumatoid arthritis (RA) were examined and the associations between CitH3 levels and disease variables were investigated.... Serum CitH3 levels were measured using an enzyme-linked immunosorbent assay in 151 RA patients (69 with highly, 32 with moderately, and 20 with mildly active RA and 30 with RA in remission) and 56 hea... CitH3 concentration was more upregulated in patients with highly and moderately active RA than in those with mild activity and remission. The area under the curve for CitH3 was 0.825 for discriminatin... CitH3 is significantly associated with disease activity and could serve as a useful candidate biomarker to assess disease activity in patients with RA....

Is dementia more likely following traumatic brain injury? A systematic review.

The association between traumatic brain injury (TBI) and dementia is controversial, and of growing importance considering the ageing demography of TBI.... To review the scope and quality of the existing literature investigating the relationship between TBI and dementia.... We conducted a systematic review following PRISMA guidelines. Studies that compared TBI exposure and dementia risk were included. Studies were formally assessed for quality with a validated quality-as... 44 studies were included in the final analysis. 75% (n = 33) were cohort studies and data collection was predominantly retrospective (n = 30, 66.7%). 25 studies (56.8%) found a positive relationship b... Our review suggests a relationship between TBI and dementia, but we are unable to predict the risk of dementia for an individual following TBI. Our conclusions are limited by heterogeneity in both exp...